mTOR Inhibitor Treatment of Pancreatic Cancer in a Patient With Peutz-Jeghers Syndrome

被引:68
作者
Klumpen, Heinz-Josef [1 ]
Queiroz, Karla C. S. [1 ]
Spek, C. Arnold [1 ]
van Noesel, Carel J. M.
Brink, Helmy C.
de Leng, Wendy W. J. [2 ]
de Wilde, Roeland F. [2 ]
Mathus-Vliegen, Elisabeth M. H.
Offerhaus, G. Johan A. [2 ]
Alleman, Maarten A. [3 ]
Westermann, Anneke M.
Richel, Dirk J.
机构
[1] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
[3] Isala Hosp, Zwolle, Netherlands
关键词
LKB1; SUPPRESSION; POLYPOSIS; RAPAMYCIN; ARREST; NSCLC; RISK;
D O I
10.1200/JCO.2010.32.7825
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E150 / E153
页数:4
相关论文
共 15 条
[1]   Very high risk of cancer in familial Peutz-Jeghers syndrome [J].
Giardiello, FM ;
Brensinger, JD ;
Tersmette, AC ;
Goodman, SN ;
Petersen, GM ;
Booker, SV ;
Cruz-Correa, M ;
Offerhaus, JA .
GASTROENTEROLOGY, 2000, 119 (06) :1447-1453
[2]   Defining the role of mTOR in cancer [J].
Guertin, David A. ;
Sabatini, David M. .
CANCER CELL, 2007, 12 (01) :9-22
[3]   AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy [J].
Hardie, D. Grahame .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (10) :774-785
[4]   TARGETS FOR CELL-CYCLE ARREST BY THE IMMUNOSUPPRESSANT RAPAMYCIN IN YEAST [J].
HEITMAN, J ;
MOVVA, NR ;
HALL, MN .
SCIENCE, 1991, 253 (5022) :905-909
[5]   LKB1; linking cell structure and tumor suppression [J].
Hezel, A. F. ;
Bardeesy, N. .
ONCOGENE, 2008, 27 (55) :6908-6919
[6]   Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase [J].
Jenne, DE ;
Reimann, H ;
Nezu, J ;
Friedel, W ;
Loff, S ;
Jeschke, R ;
Müller, D ;
Back, W ;
Zimmer, M .
NATURE GENETICS, 1998, 18 (01) :38-44
[7]   LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis [J].
Katajisto, Pekka ;
Vaahtomeri, Kari ;
Ekman, Niklas ;
Ventela, Eeva ;
Ristimaki, Ari ;
Bardeesy, Nabeel ;
Feil, Robert ;
DePinho, Ronald A. ;
Makela, Tomi P. .
NATURE GENETICS, 2008, 40 (04) :455-459
[8]   LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition [J].
Mahoney, C. L. ;
Choudhury, B. ;
Davies, H. ;
Edkins, S. ;
Greenman, C. ;
van Haaften, G. ;
Mironenko, T. ;
Santarius, T. ;
Stevens, C. ;
Stratton, M. R. ;
Futreal, P. A. .
BRITISH JOURNAL OF CANCER, 2009, 100 (02) :370-375
[9]   LKB1 Haploinsufficiency Cooperates With Kras to Promote Pancreatic Cancer Through Suppression of p21-Dependent Growth Arrest [J].
Morton, Jennifer P. ;
Jamieson, Nigel B. ;
Karim, Saadia A. ;
Athineos, Dimitris ;
Ridgway, Rachel A. ;
Nixon, Colin ;
Mckay, Colin J. ;
Carter, Ross ;
Brunton, Valerie G. ;
Frame, Margaret C. ;
Ashworth, Alan ;
Oien, Karin A. ;
Evans, T. R. Jeffry ;
Sansom, Owen J. .
GASTROENTEROLOGY, 2010, 139 (02) :586-597
[10]   mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome [J].
Shackelford, David B. ;
Vasquez, Debbie S. ;
Corbeil, Jacqueline ;
Wu, Shulin ;
Leblanc, Mathias ;
Wu, Chin-Lee ;
Vera, David R. ;
Shaw, Reuben J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (27) :11137-11142